Hydralazine is a medication that functions as a direct vasodilator used primarily to treat high blood pressure. Its therapeutic purpose is to lower arterial blood pressure by relaxing vascular smooth muscle and reducing afterload on the heart. The drug works by opening atp-dependent potassium channels in vascular smooth muscle, causing an influx of potassium and hyperpolarization that leads to vessel relaxation. This pharmacologic action results in decreased systemic vascular resistance while cardiac contractility is preserved, leading to improved blood flow and reduced workload on the heart. The physiological consequence is a favorable alteration in hemodynamics that helps manage conditions such as hypertensive emergencies and certain forms of heart failure. Overall the active ingredient produces its therapeutic effect by specifically targeting and relaxing peripheral arteries, thereby restoring a more balanced circulatory state.

Hydralazine is a medication used to treat high blood pressure by relaxing blood vessels. It works by directly acting on smooth muscle in the arterial walls to reduce vascular resistance. The drug is a hydrazine derivative that influences calcium channels in vascular smooth muscle cells. By blocking calcium influx it diminishes the force of contraction in these cells. The resulting relaxation of arterioles lowers systemic blood pressure and improves cardiac output. Hydralazine also has a secondary effect of opening potassium channels which further relaxes vascular smooth muscle. This dual action on calcium and potassium pathways enhances its ability to reduce afterload on the heart. Clinically it is used to manage severe hypertension and to improve symptoms in certain heart failure patients.

Hydralazine can cause a rapid drop in blood pressure especially when standing up quickly. Some individuals may experience a rapid heartbeat or palpitations. Headache and dizziness are common complaints during treatment. Skin reactions such as rash or itching may occur in certain patients. The medication can lead to a metallic taste in the mouth or gastrointestinal discomfort. Swelling of the ankles or feet has been reported in some cases. Rarely liver function abnormalities or nerve irritation may be observed.

Hydralazine may cause headache in some patients. It can lead to reflex tachycardia as a common response. Some individuals experience edematous swelling of the ankles and feet. The drug may cause a lupus like syndrome with rash and joint pain. It can result in low blood pressure especially when standing up quickly. Rarely it may affect heart rhythm or cause elevation of liver enzymes.